Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients

References

• CollinsAJFoleyRNHerzogCExcerpts from the US Renal Data System 2009 Annual Data ReportAm J Kidney Dis2010551 Suppl 1S1S420A6A7
   PubMed Web of Science ®Google Scholar
• CollinsAJCardiovascular mortality in end-stage renal diseaseAm J Med Sci2003325416316712695721
   PubMed Web of Science ®Google Scholar
• SchiffrinELLipmanMLMannJFChronic kidney disease: effects on the cardiovascular systemCirculation20071161859717606856
   PubMed Web of Science ®Google Scholar
• CarreroJJStenvinkelPCuppariLEtiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM)J Ren Nutr2013232779023428357
   PubMed Web of Science ®Google Scholar
• HimmelfarbJStenvinkelPIkizlerTAHakimRMThe elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney Int20026251524153812371953
   PubMed Web of Science ®Google Scholar
• VaziriNDCauses of dysregulation of lipid metabolism in chronic renal failureSemin Dial200922664465120017835
   PubMed Web of Science ®Google Scholar
• Kalantar-ZadehKIkizlerTABlockGAvramMMKoppleJDMalnutrition-inflammation complex syndrome in dialysis patients: causes and consequencesAm J Kidney Dis200342586488114582032
   PubMed Web of Science ®Google Scholar
• GalliFFloridiAGFloridiABuoncristianiUAccumulation of vitamin E metabolites in the blood of renal failure patientsClin Nutr200423220521215030960
   PubMed Web of Science ®Google Scholar
• RiccioniGNDOScottiLCirculating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: a case control studyInt J Immunopathol Pharmacol201023132733420378019
   PubMed Web of Science ®Google Scholar
• EspeKMRailaJHenzeALow plasma alpha-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patientsClin J Am Soc Nephrol20138345245823335039
   PubMed Web of Science ®Google Scholar
• VaziriNDDyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequencesAm J Physiol Renal Physiol20062902F262F27216403839
   PubMed Web of Science ®Google Scholar
• PennellPLeclercqBDelahuntyMIWaltersBAThe utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney diseaseClin Nephrol200666533634717140163
   PubMed Web of Science ®Google Scholar
• VaziriNDLiangKParksJSDown-regulation of hepatic lecithin: cholesterol acyltransferase gene expression in chronic renal failureKidney Int20015962192219611380821
   PubMed Web of Science ®Google Scholar
• MoradiHPahlMVElahimehrRVaziriNDImpaired antioxidant activity of high-density lipoprotein in chronic kidney diseaseTransl Res20091532778519138652
   PubMed Web of Science ®Google Scholar
• VaziriNDNavabMFogelmanAMHDL metabolism and activity in chronic kidney diseaseNat Rev Nephrol20106528729620308998
   PubMed Web of Science ®Google Scholar
• JiangQChristenSShigenagaMKAmesBNGamma-tocopherol, the major form of vitamin E in the US diet, deserves more attentionAm J Clin Nutr200174671472211722951
   PubMed Web of Science ®Google Scholar
• SerbinovaEKaganVHanDPackerLFree radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienolFree Radic Biol Med19911052632751649783
   PubMed Web of Science ®Google Scholar
• SuzukiYJTsuchiyaMWassallSRStructural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potencyBiochemistry1993324010692106998399214
   PubMed Web of Science ®Google Scholar
• FrankJChinXWSchraderCEckertGPRimbachGDo tocotrienols have potential as neuroprotective dietary factors?Ageing Res Rev201211116318021763788
   PubMed Web of Science ®Google Scholar
• AzlinaMFNafeezaMIKhalidBAA comparison between tocopherol and tocotrienol effects on gastric parameters in rats exposed to stressAsia Pac J Clin Nutr200514435836516326642
   PubMed Web of Science ®Google Scholar
• WuSJLiuPLNgLTTocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cellsMol Nutr Food Res200852892192918481320
   PubMed Web of Science ®Google Scholar
• HengECKarsaniSAAbdul RahmanMAbdul HamidNAHamidZWan NgahWZSupplementation with tocotrienol-rich fraction alters the plasma levels of Apolipoprotein A-I precursor, Apolipoprotein E precursor, and C-reactive protein precursor from young and old individualsEur J Nutr20135271811182023287846
   PubMed Web of Science ®Google Scholar
• BurdeosGCNakagawaKKimuraFMiyazawaTTocotrienol attenuates triglyceride accumulation in HepG2 cells and F344 ratsLipids201247547148122367056
   PubMed Web of Science ®Google Scholar
• QureshiAASamiSASalserWAKhanFASynergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humansJ Nutr Biochem200112631832911516635
   PubMed Web of Science ®Google Scholar
• MinhajuddinMBegZHIqbalJHypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic ratsFood Chem Toxicol200543574775315778015
   PubMed Web of Science ®Google Scholar
• CoombesJSFassettRGAntioxidant therapy in hemodialysis patients: a systematic reviewKidney Int201281323324621975860
   PubMed Web of Science ®Google Scholar
• DiepeveenSHVerhoevenGWVan Der PalenJEffects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trialJ Intern Med2005257543844515836660
   PubMed Web of Science ®Google Scholar
• UzumAToprakOGumustasMKCiftciSSenSEffect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysisJ Nephrol200619673974517173246
   PubMed Web of Science ®Google Scholar
• StenvinkelPHeimburgerOPaultreFStrong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureKidney Int19995551899191110231453
   PubMed Web of Science ®Google Scholar
• CarreroJJStenvinkelPInflammation in end-stage renal disease – what have we learned in 10 years?Seminars in Dialysis201023549850921039875
   PubMed Web of Science ®Google Scholar
• ChinSFIbahimJMakpolSTocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: a randomized controlled studyNutr Metab (Lond)2011814221702918
   PubMedGoogle Scholar
• SongBLDeBose-BoydRAInsig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienolsJ Biol Chem200628135250542506116831864
   PubMed Web of Science ®Google Scholar
• ParkerRAPearceBCClarkRWGordonDAWrightJJTocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductaseJ Biol Chem19932681511230112388388388
   PubMed Web of Science ®Google Scholar
• SaghaeiMRandom allocation software for parallel group randomized trialsBMC Med Res Methodol200442615535880
   PubMedGoogle Scholar
• DaudZATubieBAdamsJEffects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patientsVasc Health Risk Manag2012818719522536073
   PubMedGoogle Scholar
• LeeJKGraceKAFosterTGHow should we measure medication adherence in clinical trials and practice?Ther Clin Risk Manag20073468569018472991
   PubMedGoogle Scholar
• ChunJLeeJYeLExlerJEitenmillerRRTocopherol and tocotrienol contents of raw and processed fruits and vegetables in the United States dietJ Food Compost Anal200619196204
   Web of Science ®Google Scholar
• PiironenVSyvaojaELVaroPSalminenKKaivistoinenPTocopherols and tocotrienols in Finnish foods: vegetables, fruits and berriesJ Agric Food Chem1986344742746
   Web of Science ®Google Scholar
• FrankeAAMurphySPLaceyRCusterLJTocopherol and tocotrienol levels of foods consumed in HawaiiJ Agric Food Chem200755376977817263473
   PubMed Web of Science ®Google Scholar
• GarrowJSWebsterJQuetelet’s index (W/H2) as a measure of fatnessInt J Obesity198592147153
   PubMed Web of Science ®Google Scholar
• World Health OrganizationObesity: Preventing and Managing the Global EpidemicGenevaWorld Health Organization2000 Available from: http://libdoc.who.int/trs/WHO_TRS_894.pdfAccessed October 17, 2013
   Google Scholar
• BonaccioMBonanniAEDi CastelnuovoALow income is associated with poor adherence to a Mediterranean diet and a higher prevalence of obesity: cross-sectional results from the Moli-sani studyBMJ Open201226
   PubMed Web of Science ®Google Scholar
• HungAPupimLYuCDeterminants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilizationHemodial Int200812223624318394058
   PubMed Web of Science ®Google Scholar
• BeerenhoutCHKoomanJPvan der SandeFMHackengCLeunissenKMC-reactive protein levels in dialysis patients are highly variable and strongly related to co-morbidityNephrol Dial Transplant200318122112480998
   PubMed Web of Science ®Google Scholar
• MeuweseCLStenvinkelPDekkerFWCarreroJJMonitoring of inflammation in patients on dialysis: forewarned is forearmedNat Rev Nephrol20117316617621358695
   PubMed Web of Science ®Google Scholar
• YeunJYLevineRAMantadilokVKaysenGAC-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patientsAm J Kidney Dis200035346947610692273
   PubMed Web of Science ®Google Scholar
• BlumACostelloRSamselLVariability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapyIsr Med Assoc J2009111060260520077946
   PubMed Web of Science ®Google Scholar
• HodkovaMDusilova-SulkovaSKalousovaMInfluence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patientsRen Fail200628539539916825088
   PubMed Web of Science ®Google Scholar
• BogatyPBrophyJMBoyerLFluctuating inflammatory markers in patients with stable ischemic heart diseaseArch Intern Med2005165222122615668370
   PubMedGoogle Scholar
• MustadVASmithCARueyPPEdensNKDeMicheleSJSupplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemiaAm J Clin Nutr20027661237124312450888
   PubMed Web of Science ®Google Scholar
• MensinkRPvan HouwelingenACKromhoutDHornstraGA vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrationsAm J Clin Nutr19996922132199989682
   PubMed Web of Science ®Google Scholar
• Kujawa-SzewieczekAWiecekAPiechaGThe lipid story in chronic kidney disease: a long story with a happy end?Int Urol Nephrol20134551273128723054316
   PubMed Web of Science ®Google Scholar
• VaziriNDNorrisKCReasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populationsBlood Purif2013351–3313623343544
   PubMed Web of Science ®Google Scholar
• ZaidenNYapWNOngSGamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretionJ Atheroscler Thromb201017101019103220702976
   PubMed Web of Science ®Google Scholar
• RaderDJMolecular regulation of HDL metabolism and function: implications for novel therapiesJ Clin Invest2006116123090310017143322
   PubMed Web of Science ®Google Scholar
• GlassCPittmanRCWeinsteinDBSteinbergDDissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonadProc Natl Acad Sci U S A19838017543554396412229
   PubMed Web of Science ®Google Scholar
• PruijmMSchmidtkoJAhoAHigh prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintageTher Apher Dial201216658859423190520
   PubMed Web of Science ®Google Scholar
• PahlMVNiZSepassiLMoradiHVaziriNDPlasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD)Nephrol Dial Transplant20092482541254619297356
   PubMed Web of Science ®Google Scholar
• AldredSSozziTMudwayIAlpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjectsProteomics2006651695170316429457
   PubMed Web of Science ®Google Scholar
• CacciagiuLDGonzalezAIGomez RossoLHDL-associated enzymes and proteins in hemodialysis patientsClin Biochem201245324324822206739
   PubMed Web of Science ®Google Scholar
• PatelVRinkCGordilloGMOral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patientsJ Nutr2012142351351922298568
   PubMed Web of Science ®Google Scholar
• FairusSNorRMChengHMSundramKAlpha-tocotrienol is the most abundant tocotrienol isomer circulated in plasma and lipoproteins after postprandial tocotrienol-rich vitamin E supplementationNutr J201211522252050
   PubMed Web of Science ®Google Scholar
• KhoslaPPatelVWhinterJMPostprandial levels of the natural vitamin E tocotrienol in human circulationAntioxid Redox Signal200685–61059106816771695
   PubMed Web of Science ®Google Scholar
• FairusSNorRMChengHMSundramKPostprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of alpha-tocopherolAm J Clin Nutr200684483584217023711
   PubMed Web of Science ®Google Scholar
• YapSPYuenKHWongJWPharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food statusJ Pharm Pharmacol2001531677111206194
   PubMed Web of Science ®Google Scholar